162 related articles for article (PubMed ID: 8098351)
1. [Countermeasure for severe acute cardiomyopathies].
Nakano T; Yamakado T
Nihon Naika Gakkai Zasshi; 1993 Feb; 82(2):235-9. PubMed ID: 8098351
[No Abstract] [Full Text] [Related]
2. [Maintenance therapy and various tests during follow-up of cardiomyopathies].
Ogasawara S; Kimata S
Nihon Naika Gakkai Zasshi; 1993 Feb; 82(2):231-4. PubMed ID: 8098350
[No Abstract] [Full Text] [Related]
3. [Therapy of hypertrophic cardiomyopathy].
Cecchi F; Olivotto I
G Ital Cardiol; 1999 Oct; 29(10):1199-203. PubMed ID: 10546134
[No Abstract] [Full Text] [Related]
4. [Prognosis of hypertrophic and dilated cardiomyopathy].
Ikeda H; Imaizumi T
Nihon Rinsho; 2000 Jan; 58(1):86-92. PubMed ID: 10885294
[TBL] [Abstract][Full Text] [Related]
5. [Medical treatment for cardiomyopathies].
Suwa M
Nihon Rinsho; 2000 Jan; 58(1):59-63. PubMed ID: 10885289
[TBL] [Abstract][Full Text] [Related]
6. [Treatment of cardiomyopathies from a pathophysiological viewpoint].
Inoo T; Yokota Y
Nihon Naika Gakkai Zasshi; 1993 Feb; 82(2):226-30. PubMed ID: 8098349
[No Abstract] [Full Text] [Related]
7. [Heart failure associated with hypertrophic cardiomyopathy].
Oka N; Ohmura H; Ueda T
Nihon Rinsho; 2007 May; 65 Suppl 5():425-9. PubMed ID: 17569322
[No Abstract] [Full Text] [Related]
8. [Heart failure due to dilated cardiomyopathy].
Hiramitsu S; Miyagishima K; Mori K; Kimura H
Nihon Rinsho; 2007 May; 65 Suppl 5():421-4. PubMed ID: 17569321
[No Abstract] [Full Text] [Related]
9. Effect of the addition of a beta-blocker on left ventricular remodeling and prognosis in patients with dilated cardiomyopathy treated with angiotensin-converting enzyme inhibitor.
Hamada M; Hara Y; Ohtsuka T; Suzuki J; Saeki H; Ogimoto A; Shigematsu Y
J Cardiovasc Pharmacol; 2003 Jan; 41 Suppl 1():S5-10. PubMed ID: 12688389
[TBL] [Abstract][Full Text] [Related]
10. Medical and surgical therapy of hypertrophic cardiomyopathy.
Bonow RO; Maron BJ; Leon MB; Cannon RO; Epstein SE
Cardiovasc Clin; 1988; 19(1):221-39. PubMed ID: 2901911
[No Abstract] [Full Text] [Related]
11. [Drug therapy of dilated cardiomyopathy].
Guazzi MD; Alimento M; Mundo E; Viecca M
Cardiologia; 1985 Oct; 30(10):909-12. PubMed ID: 2878720
[No Abstract] [Full Text] [Related]
12. [Calcium antagonists in cardiomyopathy].
Takabatake Y
Nihon Rinsho; 1991 Jan; 49(1):168-75. PubMed ID: 2002597
[No Abstract] [Full Text] [Related]
13. Pediatric myocardial disease.
Towbin JA
Pediatr Clin North Am; 1999 Apr; 46(2):289-312, ix. PubMed ID: 10218076
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms in cardiomyopathies.
Goodwin JF
J Mol Cell Cardiol; 1985 Jul; 17 Suppl 2():5-9. PubMed ID: 2863388
[TBL] [Abstract][Full Text] [Related]
15. [Hypertrophic cardiomyopathy: which therapy? Comparison between beta blockers and calcium antagonists on the symptomatology and natural history of the disease].
Schiavoni G; Favuzzi A; Manzoli U
Cardiologia; 1985 Apr; 30(4):265-9. PubMed ID: 2870803
[No Abstract] [Full Text] [Related]
16. Are Angiotensin-converting enzyme inhibitors and beta-blockers ineffective in children with dilated cardiomyopathy and heart failure?
Singh TP; Almond C
J Am Coll Cardiol; 2010 Aug; 56(10):823; author reply 823-4. PubMed ID: 20797500
[No Abstract] [Full Text] [Related]
17. Cardiomyopathies in adolescents: dilated, hypertrophic, and restrictive.
Shaddy RE
Adolesc Med; 2001 Feb; 12(1):35-45. PubMed ID: 11224021
[TBL] [Abstract][Full Text] [Related]
18. [Restrictive cardiomyopathy associated with heart failure].
Konno T; Ino H; Fujino N; Hayashi K; Yamagishi M
Nihon Rinsho; 2007 May; 65 Suppl 5():430-7. PubMed ID: 17571415
[No Abstract] [Full Text] [Related]
19. Understanding the pathophysiology is the key to novel therapies for canine dilated cardiomyopathy.
Elliott J; Marr CM
Vet J; 2001 Nov; 162(3):168-9. PubMed ID: 11681866
[No Abstract] [Full Text] [Related]
20. New concepts in hypertrophic cardiomyopathies, part II.
Roberts R; Sigwart U
Circulation; 2001 Oct; 104(18):2249-52. PubMed ID: 11684639
[No Abstract] [Full Text] [Related]
[Next] [New Search]
